Atherectomy Devices Market Size, Share and Technological Advancements 2018 to 2025
Global Atherectomy Devices Market is expected to witness rapid growth over the forecast period. Increase in prevalence of Peripheral artery disease (PAD) and Deep vein thrombosis (DVT) is expected to drive the market growth over the forecast period. Increase in aging population in the US and in economically developed countries resulting in high requirement of medical devices for chronic illness. This is expected to escalate the market growth of Atherectomy devices. Major factors such as rising life expectancy declining fertility rates play a major role in Atherectomy Devices Market growth in the foreseeable future.
Global Atherectomy Devices Market is expected to witness rapid growth over the forecast period. Increase in prevalence of Peripheral artery disease (PAD) and Deep vein thrombosis (DVT) is expected to drive the market growth over the forecast period. Increase in aging population in the US and in economically developed countries resulting in high requirement of medical devices for chronic illness. This is expected to escalate the market growth of Atherectomy devices. Major factors such as rising life expectancy declining fertility rates play a major role in Atherectomy Devices Market growth in the foreseeable future.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Diabetes, high blood pressure, obesity <strong>and</strong> smoking causes the blood arteries <strong>to</strong> marrow <strong>and</strong> limit<br />
the blood supply <strong>to</strong> the heart. It is estimated that 382 billion people throughout the world have<br />
diabetes. Environmental fac<strong>to</strong>rs such as foods, viruses, <strong>to</strong>xins <strong>and</strong> unbalanced work life play a role in<br />
development of diabetes. Growing number of patients with these vascular diseases are expected <strong>to</strong><br />
proliferate the dem<strong>and</strong> for atherec<strong>to</strong>my devices. Adopting advanced technology by using laser,<br />
ultraviolet radiation <strong>and</strong> recombinant issue technology <strong>and</strong> 3D image generation provides a better<br />
scope for the <strong>Atherec<strong>to</strong>my</strong> devices market. Added benefits such as minimal incisions, higher surgical<br />
res<strong>to</strong>ration rate, low pos<strong>to</strong>perative complications increase more patients opting for atherec<strong>to</strong>my<br />
devices.<br />
New technological advancements <strong>and</strong> the recent FDA approval of Two drug coated balloons are<br />
increasing atherec<strong>to</strong>my procedural volume <strong>and</strong> driving growth in the dem<strong>and</strong> for atherec<strong>to</strong>my<br />
devices Recalls of medical devices has been a major issue in pharmaceutical industry. Every device<br />
should maintain the st<strong>and</strong>ard quality <strong>and</strong> safety measures set by the Food <strong>and</strong> Drug Administration<br />
(FDA). All the manufacturing firms should ensure that the products are safe <strong>and</strong> do not endanger<br />
the end consumer. Athrec<strong>to</strong>my devices face a <strong>to</strong>ugh competition from Catheter (Tornus) which has<br />
been developed for chronic <strong>to</strong>tal occlusion recanalization. However, Catheter has a lower success<br />
rate of only 77% as compared <strong>to</strong> the traditional atherec<strong>to</strong>my devices with 95%. Tornus catheter is<br />
also associated with longer procedural duration time with 144 minutes versus the atherec<strong>to</strong>my<br />
devices 115 minutes.<br />
Browse Full Research Report @<br />
https://www.millioninsights.com/industry-reports/atherec<strong>to</strong>my-devices-market<br />
Lack of product differentiation forms a major challenge in the atherec<strong>to</strong>my <strong>Devices</strong> market. Most<br />
companies trying <strong>to</strong> enter the market find it hard <strong>to</strong> overcome the product differentiation because<br />
they require high investment <strong>and</strong> lack resources <strong>to</strong> create products that can compete with the<br />
existing ones. High cost <strong>and</strong> limited awareness in certain regions of the world act as a restraint for<br />
the market growth. <strong>Atherec<strong>to</strong>my</strong> technique is a popular substitute for stents <strong>and</strong> angioplasty<br />
treatments. In stents <strong>and</strong> angioplasty, the deposited plaque is pushed inside the blood vessel,<br />
however in atherec<strong>to</strong>my the plaque is removed by using surgical methods. The technique has
Change language